These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

22 related articles for article (PubMed ID: 9180353)

  • 1. A fluorescence resonance energy transfer-based M2 muscarinic receptor sensor reveals rapid kinetics of allosteric modulation.
    Maier-Peuschel M; Frölich N; Dees C; Hommers LG; Hoffmann C; Nikolaev VO; Lohse MJ
    J Biol Chem; 2010 Mar; 285(12):8793-800. PubMed ID: 20083608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subtype-selective inhibition of [methyl-3H]-N-methylscopolamine binding to muscarinic receptors by alpha-truxillic acid esters.
    Lysíková M; Fuksová K; Elbert T; Jakubík J; Tucek S
    Br J Pharmacol; 1999 Jul; 127(5):1240-6. PubMed ID: 10455271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Search for the pharmacophore of bispyridinium-type allosteric modulators of muscarinic receptors.
    Botero Cid MH; Holzgrabe U; Kostenis E; Mohr K; Tränkle C
    J Med Chem; 1994 May; 37(10):1439-45. PubMed ID: 8182702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors.
    Tränkle C; Mohr K
    Mol Pharmacol; 1997 Apr; 51(4):674-82. PubMed ID: 9106634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication.
    Jepsen K; Lüllmann H; Mohr K; Pfeffer J
    Pharmacol Toxicol; 1988 Sep; 63(3):163-8. PubMed ID: 3054859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modes of allosteric interactions with free and [3H]N-methylscopolamine-occupied muscarinic M2 receptors as deduced from buffer-dependent potency shifts.
    Schröter A; Tränkle C; Mohr K
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Dec; 362(6):512-9. PubMed ID: 11138843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a multiple binding mode of bispyridinium-type allosteric modulators of muscarinic receptors.
    Kostenis E; Botero Cid HM; Holzgrabe Y; Mohr K
    Eur J Pharmacol; 1996 Oct; 314(3):385-92. PubMed ID: 8957263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric regulation of muscarinic receptors.
    Birdsall NJ; Lazareno S; Matsui H
    Prog Brain Res; 1996; 109():147-51. PubMed ID: 9009701
    [No Abstract]   [Full Text] [Related]  

  • 9. Ligands for the common allosteric site of acetylcholine M2-receptors: development and application.
    Holzgrabe U; Bender W; Cid HM; Staudt M; Pick R; Pfletschinger C; Balatková E; Tränkle C; Mohr K
    Pharm Acta Helv; 2000 Mar; 74(2-3):149-55. PubMed ID: 10812952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation.
    Kostenis E; Mohr K
    Trends Pharmacol Sci; 1996 Aug; 17(8):280-3. PubMed ID: 8810873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular rigidity and potency of bispyridinium type allosteric modulators at muscarinic M2-receptors.
    Tränkle C; Elis K; Wiese M; Mohr K
    Life Sci; 1997; 60(22):1995-2003. PubMed ID: 9180353
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.